Sequence analysis of isolates of Aspergillus from patients with chronic and allergic aspergillosis reveals a spectrum of cryptic species

Future Microbiol. 2018 Nov:13:1557-1563. doi: 10.2217/fmb-2018-0178. Epub 2018 Nov 12.

Abstract

Aim: To establish the prevalence and antifungal susceptibilities of Aspergillus cryptic species from respiratory samples. Methods: Retrospective susceptibility data on Aspergillus species cultured between 2015 and 2017 by 'high volume culture' (HVC) versus 'conventional' culture techniques.

Results: Fifty-six (2.5%) isolates were identified as Aspergillus cryptic species by sequencing of ITS, BenA and CalM gene loci. Recovery was higher in HVCs compared to conventional cultures. Common cryptic species were Aspergillus montevidensis (n = 15), A. creber (n = 11), A. sydowii (n = 5) and A. calidoustus (n = 4). Eighteen (32.1%) isolates had minimum inhibitory concentration (MIC) values ≥4 mg/l to amphotericin B, and 19.1-60.1% had MIC values ≥8 mg/l to the triazoles.

Conclusion: HVC increases the likelihood of recovery of cryptic species. MIC values to antifungals were high.

Keywords: Aspergillus; amphotericin B; cryptic species; high volume culture; molecular identification; triazole antifungals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / pharmacology
  • Antifungal Agents / pharmacology
  • Aspergillosis / microbiology*
  • Aspergillus flavus / genetics*
  • Aspergillus flavus / isolation & purification
  • Aspergillus fumigatus / genetics*
  • Aspergillus fumigatus / isolation & purification
  • Aspergillus nidulans / genetics*
  • Aspergillus nidulans / isolation & purification
  • Genes, Fungal / genetics
  • Genetic Loci / genetics
  • Humans
  • Microbial Sensitivity Tests
  • Retrospective Studies
  • Sequence Analysis, DNA*
  • Sputum / microbiology
  • Triazoles / pharmacology

Substances

  • Antifungal Agents
  • Triazoles
  • Amphotericin B